Brant Point Investment Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Brant Point Investment Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.36M	Hold	33,866	–	–	0.66%	43
2026 Q1	$4.33M	Sell	33,866 -7,376	-18%	-$921K	0.56%	47
2025 Q4	$5.03M	Hold	41,242	–	–	0.61%	50
2025 Q3	$4.13M	Hold	41,242	–	–	0.45%	58
2025 Q2	$3.42M	Sell	41,242 -7,992	-16%	-$638K	0.36%	62
2025 Q1	$3.99M	Sell	49,234 -616	-1%	-$55.1K	0.48%	53
2024 Q4	$4.49M	Hold	49,850	–	–	0.56%	53
2024 Q3	$4.93M	Hold	49,850	–	–	0.54%	49
2024 Q2	$4.62M	Buy	49,850 +27,592	+124%	+$2.47M	0.41%	50
2024 Q1	$2.11M	Buy	22,258 +5,000	+29%	+$464K	0.18%	74
2023 Q4	$1.54M	Sell	17,258 -97	-0.6%	-$7.2K	0.13%	96
2023 Q3	$1.27M	Sell	17,355 -347	-2%	-$27.7K	0.12%	92
2023 Q2	$1.47M	Sell	17,702 -61	-0.3%	-$5.1K	0.34%	65
2023 Q1	$1.35M	Hold	17,763	–	–	0.23%	77
2022 Q4	$1.47M	Sell	17,763 -13,693	-44%	-$1.11M	0.22%	69
2022 Q3	$2.5M	Hold	31,456	–	–	0.37%	71
2022 Q2	$2.34M	Sell	31,456 -8,800	-22%	-$661K	0.35%	62
2022 Q1	$3.62M	Sell	40,256 -20,000	-33%	-$1.85M	0.41%	66
2021 Q4	$6.75M	Buy	60,256 +20,128	+50%	+$2.43M	1.06%	38
2021 Q3	$5.04M	Buy	40,128 +8,128	+25%	+$1.05M	0.44%	54
2021 Q2	$4.33M	Hold	32,000	–	–	0.4%	72
2021 Q1	$4.34M	Hold	32,000	–	–	0.47%	72
2020 Q4	$4.5M	Hold	32,000	–	–	0.53%	63
2020 Q3	$3.57M	Hold	32,000	–	–	0.31%	75
2020 Q2	$3.58M	Buy	+32,000	New	+$3.15M	0.35%	63

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Brant Point Investment Management's XBI Position: Q2 2026 in Review

Brant Point Investment Management held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 33,866 shares worth $5.36M. The position accounts for 0.66% of the portfolio, ranked #43.

Brant Point Investment Management first reported a position in XBI in Q2 2020 and has held it in 25 quarters since. The position peaked at $6.75M in Q4 2021. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Brant Point Investment Management held 33,866 shares of State Street SPDR S&P Biotech ETF worth $5.36M as of Q2 2026.
Brant Point Investment Management left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.66% of Brant Point Investment Management's portfolio in Q2 2026, its #43 holding.
Brant Point Investment Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2020 and has held it in 25 quarters since.
Brant Point Investment Management's State Street SPDR S&P Biotech ETF position peaked at $6.75M in Q4 2021.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Brant Point Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.